Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push 

Reuters

Fri, January 30, 2026 astatine 10:08 AM CST 1 min read

WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced connected Friday that it volition physique a pharmaceutical manufacturing installation successful Pennsylvania, ​its 4th caller tract successful an effort to grow ‌U.S. accumulation and bolster aesculapian proviso chains.

The $3.5 cardinal works volition marque Lilly's injectable ‌weight-loss medications, including retatrutide, the institution said successful a statement. That next-generation obesity cause has outperformed Lilly's blockbuster cause Zepbound.

Drugmakers are rushing to grow U.S. accumulation arsenic President Donald Trump has threatened to ⁠impose import tariffs connected ‌pharmaceutical products.

Companies including Lilly, Pfizer, and Merck person pledged billions successful home concern to debar penalties. Lilly ‍said past twelvemonth that it would put implicit $27 cardinal successful 4 caller U.S. manufacturing sites, and has said it volition grow accumulation astatine ​others.

Lilly, the world's astir invaluable drugmaker by marketplace value, has ‌been racing against Danish rival Novo Nordisk to conscionable surging request for GLP-1 weight-loss drugs. The institution plans to motorboat its much-anticipated weight-loss pill successful respective countries astatine a $150-a-month currency terms arsenic it works towards U.S. support successful the coming months.

Construction astatine the ⁠Lehigh Valley tract is expected to ​begin successful 2026 and the works volition ​be operational successful 2031, the institution said.

The tract was selected from much than 300 applications and was ‍chosen successful portion ⁠for its proximity to universities and its existing infrastructure, the institution said.

The concern is the largest by a beingness sciences ⁠company successful Pennsylvania past and volition make astatine slightest 850 caller jobs, said ‌Governor Josh Shapiro successful a statement.

(Reporting by Leah Douglas ‌in Washington;Editing by Nick Zieminski)